Innovaderma PLC
LSE:IDP
Cash Flow Statement
Cash Flow Statement
Innovaderma PLC
| Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(6)
|
(2)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
(0)
|
0
|
|
| Cash Taxes Paid |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
0
|
0
|
0
|
0
|
(1)
|
3
|
5
|
(1)
|
(2)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(2)
-284%
|
0
N/A
|
1
+1 238%
|
0
N/A
|
(1)
N/A
|
(1)
+49%
|
(0)
+43%
|
(3)
-644%
|
(4)
-37%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(2)
|
(2)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Other Items |
0
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+38%
|
(2)
-1 283%
|
(2)
-18%
|
0
N/A
|
(0)
N/A
|
(0)
+24%
|
(0)
+82%
|
(0)
-622%
|
(0)
+28%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
2
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
1
|
1
|
|
| Other |
(0)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash from Financing Activities |
1
N/A
|
4
+222%
|
4
-10%
|
(0)
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
5
+23%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
0
|
(0)
|
0
|
2
|
2
|
(0)
|
1
|
1
|
|
| Net Change in Cash |
0
N/A
|
1
+1 565%
|
2
+28%
|
(1)
N/A
|
0
N/A
|
0
N/A
|
1
+149%
|
(0)
N/A
|
2
N/A
|
2
+4%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(1)
N/A
|
(3)
-202%
|
(2)
+24%
|
(1)
+44%
|
0
N/A
|
(2)
N/A
|
(1)
+50%
|
(0)
+64%
|
(3)
-902%
|
(4)
-29%
|
|